TTAB Oppositions 91266671
USPTO Oppositions proceeding 91266671, filed 2020-12-22. Status: Terminated.
Proceeding Facts
| Proceeding Number | 91266671 |
|---|---|
| Type | Oppositions |
| Status | Terminated |
| Filing Date | 2020-12-22 |
| Last Activity | 2022-06-01 |
| Days Active | 1972 |
Parties
- Oncogen Pharma (Malaysia) Sdn. Bhd. — Defendant
- Astex Pharmaceuticals, Inc. — Plaintiff
Plaintiff Marks
- DACOGEN — Astex Pharmaceuticals, Inc.
Defendant Marks
- ONCOGEN — Oncogen Pharma (Malaysia) Sdn. Bhd.
Recent Documents
- 2022-06-01: TERMINATED — Status
- 2022-06-01: BD DECISION: OPP DISMISSED W/ PREJ — Decisions
- 2022-05-27: W/DRAW OF OPPOSITION — Withdrawals
- 2022-04-29: SUSPENDED — Status
- 2022-04-29: P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
- 2022-03-18: SUSPENDED — Status
- 2022-03-18: P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
- 2022-02-22: SUSPENDED — Status
- 2022-02-22: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
- 2021-11-22: SUSPENDED — Status
- 2021-11-22: P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
- 2021-09-11: EXTENSION OF TIME GRANTED — Extensions
- 2021-09-11: P MOT FOR EXT W/ CONSENT — Motions
- 2021-04-30: EXTENSION OF TIME GRANTED — Extensions
- 2021-04-30: D MOT FOR EXT W/ CONSENT — Motions
- 2021-04-29: P APPEARANCE / POWER OF ATTORNEY — Parties
- 2021-03-29: EXTENSION OF TIME GRANTED — Extensions
- 2021-03-26: P MOT FOR EXT W/ CONSENT — Motions
- 2021-01-29: ANSWER — Pleadings
- 2020-12-22: INSTITUTED — Status
- 2020-12-22: NOTICE AND TRIAL DATES SENT; ANSWER DUE: — Scheduling
- 2020-12-22: FILED AND FEE — Fees